Cancer · 1983 · 37 citations · 17 references
MedicineOncologySurgeryGenitourinary OncologySurgical OncologyUrologic OncologyBladder CancerBladder SurgeryUrogenital Oncology SurgeryUrothelial CarcinomaBladder PathologyBladder Tumor SurgeryMucosal Biopsy Site EvaluationPrognostic Factors AnalysisUrothelial Dysplasia
Thirty-three patients with bladder cancer of categories pT1 or pT2 were treated by transurethral resection alone. At the initial diagnosis random preselected site mucosal biopsies were obtained to demonstrate the presence or absence of concomitant urothelial dysplasia. A statistically significant (P less than 0.01) relationship was found between the presence or absence of concomitant urothelial dysplasia and the development of new occurrence or the absence of recurrence at cystoscopic follow-up. Four of six patients with concomitant carcinoma in situ developed invasive bladder cancer within 6 months demonstrating the serious prognostic significance of this entity. Thus, the presence or absence of concomitant urothelial dysplasia at the initial diagnosis of invasive bladder cancer seems to be an important prognostic factor for future new occurrences.
17
The TNM Classification of Malignant Tumours
E. C. Easson · British Journal of Cancer · 1974 · 1K citations · Full text
Bladder carcinoma as a systemic disease
George R. Prout, Pamela P. Griffin, William U. Shipley · Cancer · 1979 · 195 citations · Full text
Mapping cancerous and precancerous bladder changes
Urology · 1974 · 155 citations